The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
We studied 211 hyperandrogenic women with respect to clinical presentation, basal androgen levels, and the degree of cortisol and androgen suppression during a 48-h low-dose (2 mg) dexamethasone-suppression test (LDDST) to exclude ovarian and adrenal tumors. In 42 women with elevated testosterone le...
Autors principals: | Kaltsas, G, Isidori, A, Kola, B, Skelly, R, Chew, S, Jenkins, P, Monson, J, Grossman, AB, Besser, G |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2003
|
Ítems similars
-
Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
per: Kaltsas, G, et al.
Publicat: (2003) -
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
per: Isidori, A, et al.
Publicat: (2003) -
Discriminatory value of low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome - Response
per: Isidori, A, et al.
Publicat: (2004) -
Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
per: Kaltsas, G, et al.
Publicat: (2003) -
Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
per: Monson, J, et al.
Publicat: (2001)